vs
Side-by-side financial comparison of ESAB Corp (ESAB) and LifeStance Health Group, Inc. (LFST). Click either name above to swap in a different company.
ESAB Corp is the larger business by last-quarter revenue ($727.8M vs $382.2M, roughly 1.9× LifeStance Health Group, Inc.). ESAB Corp runs the higher net margin — 7.5% vs 3.1%, a 4.5% gap on every dollar of revenue. On growth, LifeStance Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs 8.5%). ESAB Corp produced more free cash flow last quarter ($70.3M vs $46.6M). Over the past eight quarters, LifeStance Health Group, Inc.'s revenue compounded faster (12.8% CAGR vs 2.8%).
ESAB, Elektriska Svetsnings-Aktiebolaget, is an American-Swedish industrial company.
Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.
ESAB vs LFST — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $727.8M | $382.2M |
| Net Profit | $54.8M | $11.7M |
| Gross Margin | 37.0% | — |
| Operating Margin | 14.6% | 4.7% |
| Net Margin | 7.5% | 3.1% |
| Revenue YoY | 8.5% | 17.4% |
| Net Profit YoY | 2.1% | 264.1% |
| EPS (diluted) | $0.90 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $727.8M | $382.2M | ||
| Q3 25 | $715.6M | $363.8M | ||
| Q2 25 | $678.1M | $345.3M | ||
| Q1 25 | — | $333.0M | ||
| Q4 24 | $670.8M | $325.5M | ||
| Q3 24 | $673.3M | $312.7M | ||
| Q2 24 | $707.1M | $312.3M | ||
| Q1 24 | $689.7M | $300.4M |
| Q4 25 | $54.8M | $11.7M | ||
| Q3 25 | $66.9M | $1.1M | ||
| Q2 25 | $67.4M | $-3.8M | ||
| Q1 25 | — | $709.0K | ||
| Q4 24 | $53.7M | $-7.1M | ||
| Q3 24 | $68.2M | $-6.0M | ||
| Q2 24 | $82.9M | $-23.3M | ||
| Q1 24 | $60.0M | $-21.1M |
| Q4 25 | 37.0% | — | ||
| Q3 25 | 37.2% | — | ||
| Q2 25 | 37.6% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 38.5% | — | ||
| Q3 24 | 37.7% | — | ||
| Q2 24 | 38.2% | — | ||
| Q1 24 | 37.0% | — |
| Q4 25 | 14.6% | 4.7% | ||
| Q3 25 | 15.2% | 2.0% | ||
| Q2 25 | 16.2% | -0.9% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | 16.6% | 0.3% | ||
| Q3 24 | 15.7% | 0.0% | ||
| Q2 24 | 16.9% | -5.1% | ||
| Q1 24 | 16.0% | -5.6% |
| Q4 25 | 7.5% | 3.1% | ||
| Q3 25 | 9.3% | 0.3% | ||
| Q2 25 | 9.9% | -1.1% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | 8.0% | -2.2% | ||
| Q3 24 | 10.1% | -1.9% | ||
| Q2 24 | 11.7% | -7.5% | ||
| Q1 24 | 8.7% | -7.0% |
| Q4 25 | $0.90 | — | ||
| Q3 25 | $1.09 | — | ||
| Q2 25 | $1.10 | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0.87 | — | ||
| Q3 24 | $1.11 | — | ||
| Q2 24 | $1.35 | — | ||
| Q1 24 | $0.98 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $218.2M | $248.6M |
| Total DebtLower is stronger | $1.3B | $282.8M |
| Stockholders' EquityBook value | $2.1B | $1.5B |
| Total Assets | $4.9B | $2.2B |
| Debt / EquityLower = less leverage | 0.63× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $218.2M | $248.6M | ||
| Q3 25 | $258.2M | $203.9M | ||
| Q2 25 | $291.3M | $188.9M | ||
| Q1 25 | — | $134.3M | ||
| Q4 24 | $249.4M | $154.6M | ||
| Q3 24 | $253.7M | $102.6M | ||
| Q2 24 | $228.5M | $87.0M | ||
| Q1 24 | $76.5M | $49.5M |
| Q4 25 | $1.3B | $282.8M | ||
| Q3 25 | $1.1B | $284.6M | ||
| Q2 25 | $1.1B | $286.4M | ||
| Q1 25 | — | $288.2M | ||
| Q4 24 | $1.1B | $290.0M | ||
| Q3 24 | $1.1B | $287.3M | ||
| Q2 24 | $1.1B | $288.0M | ||
| Q1 24 | $992.8M | $288.8M |
| Q4 25 | $2.1B | $1.5B | ||
| Q3 25 | $2.1B | $1.5B | ||
| Q2 25 | $1.9B | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | $1.8B | $1.4B | ||
| Q3 24 | $1.8B | $1.4B | ||
| Q2 24 | $1.7B | $1.4B | ||
| Q1 24 | $1.6B | $1.4B |
| Q4 25 | $4.9B | $2.2B | ||
| Q3 25 | $4.4B | $2.1B | ||
| Q2 25 | $4.2B | $2.1B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | $4.0B | $2.1B | ||
| Q3 24 | $4.1B | $2.1B | ||
| Q2 24 | $4.0B | $2.1B | ||
| Q1 24 | $3.8B | $2.1B |
| Q4 25 | 0.63× | 0.19× | ||
| Q3 25 | 0.51× | 0.19× | ||
| Q2 25 | 0.55× | 0.19× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | 0.60× | 0.20× | ||
| Q3 24 | 0.59× | 0.20× | ||
| Q2 24 | 0.63× | 0.20× | ||
| Q1 24 | 0.61× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $81.5M | $57.6M |
| Free Cash FlowOCF − Capex | $70.3M | $46.6M |
| FCF MarginFCF / Revenue | 9.7% | 12.2% |
| Capex IntensityCapex / Revenue | 1.5% | 2.9% |
| Cash ConversionOCF / Net Profit | 1.49× | 4.93× |
| TTM Free Cash FlowTrailing 4 quarters | $238.0M | $110.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $81.5M | $57.6M | ||
| Q3 25 | $46.6M | $27.3M | ||
| Q2 25 | $35.4M | $64.4M | ||
| Q1 25 | — | $-3.1M | ||
| Q4 24 | $126.9M | $62.3M | ||
| Q3 24 | $101.0M | $22.7M | ||
| Q2 24 | $83.0M | $44.1M | ||
| Q1 24 | $44.5M | $-21.8M |
| Q4 25 | $70.3M | $46.6M | ||
| Q3 25 | $37.4M | $17.0M | ||
| Q2 25 | $28.1M | $56.6M | ||
| Q1 25 | — | $-10.3M | ||
| Q4 24 | $102.2M | $56.0M | ||
| Q3 24 | $90.4M | $17.7M | ||
| Q2 24 | $74.0M | $39.0M | ||
| Q1 24 | $37.1M | $-26.9M |
| Q4 25 | 9.7% | 12.2% | ||
| Q3 25 | 5.2% | 4.7% | ||
| Q2 25 | 4.1% | 16.4% | ||
| Q1 25 | — | -3.1% | ||
| Q4 24 | 15.2% | 17.2% | ||
| Q3 24 | 13.4% | 5.7% | ||
| Q2 24 | 10.5% | 12.5% | ||
| Q1 24 | 5.4% | -9.0% |
| Q4 25 | 1.5% | 2.9% | ||
| Q3 25 | 1.3% | 2.8% | ||
| Q2 25 | 1.1% | 2.2% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | 3.7% | 1.9% | ||
| Q3 24 | 1.6% | 1.6% | ||
| Q2 24 | 1.3% | 1.6% | ||
| Q1 24 | 1.1% | 1.7% |
| Q4 25 | 1.49× | 4.93× | ||
| Q3 25 | 0.70× | 25.34× | ||
| Q2 25 | 0.53× | — | ||
| Q1 25 | — | -4.36× | ||
| Q4 24 | 2.36× | — | ||
| Q3 24 | 1.48× | — | ||
| Q2 24 | 1.00× | — | ||
| Q1 24 | 0.74× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESAB
| Consumable Products | $477.9M | 66% |
| Equipment Products | $249.9M | 34% |
LFST
Segment breakdown not available.
